Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 7:6:162.
doi: 10.3389/fpubh.2018.00162. eCollection 2018.

Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective

Koby Cohen  1 , Aviv M Weinstein  1
Affiliations
Review

Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective

Koby Cohen et al. Front Public Health. .

Abstract

There is a growing use of novel psychoactive substances containing synthetic cannabinoids. Synthetic cannabinoid products have effects similar to those of natural cannabis, yet, these drugs are more potent and dangerous, and have been associated with dangerous adverse effects. Here, we review current literature on the epidemiology, acute, and chronic effects of synthetic and natural cannabinoid-based drugs. Synthetic drugs contain a mixture of psychoactive compounds that mostly bind cannabinoid receptors with high potency. These synthetic drugs replicate the effects of natural cannabis and Δ9-tetrahydrocannabinol but they induce more severe adverse effects including respiratory difficulties, hypertension, tachycardia, chest pain, muscle twitches, acute renal failure, anxiety, agitation, psychosis, suicidal ideation, and cognitive impairment. Chronic use of synthetic cannabinoids has been associated with serious psychiatric and medical conditions and even death. Given the growing popularity in the use of cannabinoid-based drugs and their harmful potential, there is a need for further research in this field.

Keywords: addiction; cannabis; drug abuse; novel psychoactive drugs; synthetic cannabinoids.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet (2009) 374:1383–91. 10.1016/S0140-6736(09)61037-0 - DOI - PubMed
    1. Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. . Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry (2016) 73:292–7. 10.1001/jamapsychiatry.2015.3278 - DOI - PubMed
    1. UNDOC World Drug Report 2015. Vienna: United Nation Office on Drugs and Crime 2016; (2016).
    1. Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy (2013) 33:195–209. 10.1002/phar.1187 - DOI - PubMed
    1. Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, et al. . Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. Epidemiol Preven. (2017) 41:279–93. 10.19191/EP17.5-6.AD01.069 - DOI - PubMed